Send to

Choose Destination
Pulm Pharmacol Ther. 1998 Feb;11(1):1-6.

Effects of S-salbutamol on human isolated bronchus.

Author information

Quintiles Scotland Ltd, Research Avenue South, Heriot Watt University Research Park, Edinburgh, Riccarton, EH14 4AP, UK.

Erratum in

  • Pulm Pharmacol Ther 1998 Apr-Jun;11(2-3):243.


A range of stimuli have been used to determine the effect of S-salbutamol on contractile responses of human isolated bronchus. Significant augmentation of contraction was evident during responses to histamine or LTC4 but responses to EFS, methacholine, bradykinin and capsaicin were not influenced and allergic bronchospasm was significantly impaired by prior exposure to S-salbutamol. Since R-salbutamol relaxes human isolated bronchus, the capacity of S-salbutamol to enhance contractile responses to histamine or LTC4 cannot be attributed to activation of beta2-adrenoceptors. It is concluded, therefore, that these effects of S-salbutamol represent distinct pharmacological actions of the distomer. It is also suggested that the capacity of S-salbutamol to augment contraction of airway smooth muscle may contribute to hyperreactivity towards spasmogens when racemic salbutamol is used for symptom relief in asthma and chronic obstructive pulmonary disease (COPD).

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center